Protective effect of Andrographis paniculata and andrographolide on cyclophosphamide-induced urothelial toxicity

Integrative Cancer Therapies

Volumn 5, Issue 3, 2006, Pages 244-251

  Sheeja, K ^a   Kuttan, Girija ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

Andrographis paniculata; Andrographolide; Cyclophosphamide; Cytokines; MESNA; Urothelial toxicity

Indexed keywords

ANDROGRAPHIS PANICULATA EXTRACT; ANDROGRAPHOLIDE; CYCLOPHOSPHAMIDE; CYTOKINE; GAMMA INTERFERON; GLUTATHIONE; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ANDROGRAPHIS PANICULATA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER; COLOR; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOSE RESPONSE; HISTOPATHOLOGY; INFLAMMATION; MALE; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; URINARY TRACT DISEASE; UROTHELIAL TOXICITY;

ANDROGRAPHIS; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CYCLOPHOSPHAMIDE; DITERPENES; DRUG TOXICITY; MICE; PHYTOTHERAPY; PLANT EXTRACTS; PROTECTIVE AGENTS; UROTHELIUM;

EID: 33746587712     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735406291984     Document Type: Article

References (42)

1. Morais MM, Belarmino-Filho JN, Brito GAC, Ribeiro RA. Pharmacological and histopathological study of cyclophosphamide-induced hemorrhagic cystitis - comparison of the effect of dexamethasone and Mesna. Braz J Med Biol Res. 1999;32:1211-1215.
2. Fleming RE. An overview of cyclophosphamide and ifosfamide pharmacology. Pharmacotherapy. 1997;17:146s-154s.
3. Mirkes PE. Cyclophosphamide teratogenesis: a review. Teratogen Carcinogen Mutagen. 1985;5:75-88.
4. Foad BSI, Hess EV. Urinary bladder complication with therapy. Arch Intern Med. 1976;136:616-619.
5. Boddy AV, Yule SM. Metabolism and pharmacokinetics of oxazaphosphorines. Clin Pharmacokinet. 2000;38:291-304.
6. Cox PJ. Cyclophosphamide cystitis - identification of acrolein as the causative agent. Biochem Pharmacol. 1979;28:2045-2049.
7. Berlin L, MuHugh SL, eds. Physician's Drug Handbook. 8th ed. Spring House, Pa: Spring House; 1999.
8. Trigg ME, O'Reilly J, Rumelhart S, Morgan D, Holida M, De Alarcon P. Prostaglandin E1 bladder instillations to control severe hemorrhagic cystitis. J Urol. 1990;143:92-94.
9. Mohiuddin J, Prentice HG, Schey S, Blacklock H, Dandona P. Treatment of cyclophosphamide-induced cystitis with prostaglandin E2. Ann Intern Med. 1984;101:142.
10. Shurafa M, Shumaker E, Cronin S. Prostaglandin F2-alpha bladder irrigation for control of intractable cyclophosphamide induced hemorrhagic cystitis. J Urol. 1987;137:1230-1231.
11. Grinberg-Funes DJ, Sheldon C, Weiss M. The use of prostaglandin F2-alpha for the prophylaxis of cyclophosphamide-induced cystitis in rats. J Urol. 1990;28:1500-1504.
12. Kumar KBH, Kuttan R. Chemoprotective activity of an extract of Phyllanthus amarus against cyclophosphamide-induced toxicity in mice. Phytomedicine. 2005;12:495-500.
13. Bin-Hafeez B, Ahmad I, Haque R, Raisuddin S. Protective effect of Cassia occidentales L. on cyclophosphamide-induced suppression of humoral immunity in mice. J Ethnopharmacol. 2001;75:13-18.
14. Haque R, Bin-Hafeez B, Ahmad I, Parvez S, Pandey S, Raisuddin S. Protective effect of Emblica officinalis Gaertn. in cyclophosphamide-treated mice. Human Exp Toxicol. 2001;20:643-650.
15. Sharma N, Trikha P, Athar M, Raisuddin S. Inhibitory effect of Emblica officinalis on the in vivo clastogenicity of benzo[a]pyrene and cyclophosphamide in mice. Human Exp Toxicol. 2000;19:377-384.
16. Xu X, Malave A. Protective effect of berberine on cyclophosphamide- induced haemorrhagic cystitis in rats. Pharmacol Toxicol. 2001;88:232-237.
17. Davis L, Kuttan G. Effect of Withania somnifera on cyclophosphamide- induced urotoxicity. Cancer Lett. 2001;148:9-17.
18. Manesh C, Kuttan G. Alleviation of cyclophosphamide-induced urotoxicity by naturally occurring sulphur compounds. J Exp Clin Cancer Res. 2002;24:509-517.
19. Manesh C, Kuttan G. Effect of naturally occurring isothiocyanates in the inhibition of cyclophosphamide-induced urotoxicity. Phytomedicine. 2005;12:487-493.
20. Gupta AK, ed. Review on Indian Medicinal Plants. Vol 1. New Delhi, India: (Ard-Alli)-ICMR; 2004.
21. Zhang XF, Tan BK. Anti-diabetic property of ethanolic extract of Andrographis paniculata in streptozotocin-diabetic rats. Acta Pharmacol Sin. 2000;21:1157-1164.
22. Kanniappan M, Mathuram LN, Natrajan R. A study of the antipyretic effect of Chiretta (Andrographis paniculata). Ind Vet J. 1991;68:314-316.
23. Trivedi N, Rawal UM. Hepatoprotective and toxicological evaluation of Andrographis paniculata on severe liver damage. Ind J Pharmacol. 2000;32:288-293.
24. Madav S, Tripathi HC, Tandon SK, Mishra SK. Analgesic, antipyretic and antiulcerogenic effects of andrograpgholide. Ind J Pharmaceut Sci. 1994;57:121-125.
25. Shen YC, Chen CF, Chiou WF. Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism(s) involved in its anti-inflammatory effect. Br J Pharmacol. 2002;2:399-406.
26. Handa SS, Sharma A. Hepatoprotective activity of andrographolide from Andrographis paniculata against carbon tetrachloride. Ind J Med Res. 1990;92:276-283.
27. Moron MA, De Pierre JW, Mannerrick B. Levels of glutathione-s-transferase activities in rat liver. Biochem Biophys Acta. 1979;582:67-68.
28. Lowry OH, Rosenbrough NJ, Farr AL. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265-275.
29. Markus L, Jorg AK, Ralph AR. Immunostimulatory effects of low dose cyclophosphamide are controlled by inducible nitric oxide synthase. Cancer Res. 2005;12:5027-5030.
30. Berrigan MJ, Marinello AJ, Pavelic ZP, Williams CJ, Struck RF, Gurtoo HL. Protective role of thiols in cyclophosphamide-induced urotoxicity and depression of hepatic drug metabolism. Cancer Res. 1982;42:3688-3695.
31. Ozcan A, Korkmaz A, Oter S, Coskun O. Contribution of flavonoid antioxidants to the protective effect of mesna in cyclophosphamide-induced cystitis in rats. Arch Toxicol. 2005;8:461-465.
32. Haque R, Bin-Hafeez B, Parvez S, Sayeed I, Ali M, Raisuddin S. Aqueous extract of walnut (Juglans regia L.) protects mice against cyclophosphamide- induced biochemical toxicity. Human Exp Toxicol. 2003;22:473-480.
33. Xu X, Cubeddu LX, Malave A. Expression of inducible nitric oxide synthase in primary culture of rat smooth muscle cells by plasma from cyclophosphamide-treated rats. Eur J Pharmacol. 2001:416:1-9.
34. McCafferty DM, Mudgett JS, Swain MG, Kubes P. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology. 1997;112:1022-1027.
35. Parkinson JE, Mitrovic B, Merrill JE. The role of nitric oxide in multiple sclerosis. J Mol Med. 1997;75:174-186.
36. Bagasra O, Michaels FH, Zheng YM, et al. Activation of inducible form of nitric oxide synthase in the brain of patients with multiple sclerosis. Proc Natl Acad Sci U S A. 1995;92:12041-12045.
37. Zhang H, Chen X, Teng X, Snead C, Catravas JD. Molecular cloning and analysis of the rat inducible nitric oxide synthase gene promoter in aortic smooth muscle cells. Biochem Pharmacol. 1998;55:1873-1880.
38. Busse R, Mulsch A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cell. FEBS Lett. 1990;275:87-90.
39. Galea E, Feinstein DL, Reis DJ. Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures. Proc Natl Acad Sci U S A. 1992;89:10945-10949.
40. Kaprowski H, Zheng YM, Heber-Katz E, et al. In vivo expression of nitric oxide synthase in experimentally induced neurological disease. Proc Natl Acad Sci U S A. 1993;90:3024-3027.
41. Souza-Filho MVP, Lima MVA, Pompeu MML, Ballejo G, Cunha FQ, Ribeiro RA. Involvement of nitric oxide in the pathogeriesis of cyclophosphamide-induced hemorrhagic cystitis. Am J Pathol. 1997;150:247-256.
42. Batkhuu J, Hattori K, Takano F, Fushiya S, Oshiman K, Fujimiya Y. Suppression of NO production in activated macrophages in vitro and ex vivo by neoandrographolide isolated from Andrographis paniculata. Biol Phar Bull. 2002;9:1169-1174.